Associate Director Stone says the injection, while not a cure, “will help reduce the health impact if accidental exposure occurs.“ U.S. Food and Drug Administration (FDA) has approved…
Read MorePharmaceuticals
Nationwide Cell Phone Outage And Pharmacy Cyber Attack Occur
Concerns regarding cyber and cell network infrastructure increase. Thousands of mobile phone customers had no service Thursday morning as cell service providers experienced network outages. Those affected could…
Read More
FDA Approves Treatment for Severe Frostbite
The injections are intended to prevent amputation of digits. The Food and Drug Administration approved a new treatment for severe frostbite this week that is intended to prevent…
Read More
Senate Committee Launches Asthma Inhaler Price Investigation
Legislators note that inhalers sold in USA are significantly more expensive than in other countries. The Senate Health, Education, Labor, and Pensions (HELP) Committee sent letters this week…
Read More
FTC Bans Rite Aid From Use of Facial Recognition for 5 Years
The agency says the company was “reckless” in its use of the technology for surveillance purposes. The Federal Trade Commission (FTC) has prohibited Rite Aid from using facial…
Read More
Federal Court Issues Injunction Against Pharmaceutical Company
The corporation is prohibited from distributing drugs after not complying with federal manufacturing requirements. The District Court of Massachusetts brought a permanent injunction against Pharmasol Corporation, which is…
Read More
FTC Sues to Block Acquisition of Exclusive Drug License
The deal would give the French company a pharmaceutical monopoly over Pompe Disease therapy. The Federal Trade Commission (FTC) has taken action to prevent Sanofi from acquiring an…
Read More
Senator Sanders Plans to Work with New NIH Director
The senator believes fair pricing can be built into federal contracts with pharmaceutical companies. Senator Bernie Sanders of Vermont plans to work with the new director of the…
Read More
FDA Approves New Treatment for Rare Blood Clotting Disorder
Director Marks announced the therapy for the life-threatening disorder. The U.S. Food and Drug Administration recently approved Adzynma for patients with congenital thrombotic thrombocytopenic purpura (cTTP). The genetically…
Read More
FDA Launches Pilot Program to Develop Rare Disease Therapies
A limited number of sponsors will be allowed to participate. The U.S. Food and Drug Administration (FDA) has launched the Support for clinical Trials Advancing Rare disease Therapeutics…
Read More